Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Intitut Jules Boredt, Brussels

Semmelweis Egyetem - I. sz. Belgyógyászati Klinika, Budapest

Debreceni Egyetem Klinikai Központ, Debrecen

Universitair Ziekenhuis Gent, Ghent

New York University Langone Medical Center, New York

New York Presbyterian Hospital Columbia University Medical Center, New York

Icahn School of Medicine at Mount Sinai, New York

Roswell Park Cancer Institute, Buffalo

Rochester Skin Lymphoma Medical Group, Rochester

West Penn Hospital, Pittsburgh

The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore

Virgina Commonwealth University, Richmond

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia

Wake Forest Baptist Health, Winston-Salem

Hospital Universitario Fundacion Jimenez Diaz Preview, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hollings Cancer Center, Charleston

Emory University winship Cancer Institute, Atlanta

imCORE - Clínica Universidad de Navarra, Pamplona

Institut Universitaire du Cancer - Oncopôle, Department d'Hématologie, Toulouse

Institut Bergonié, Unicancer, Bordeaux

University of Alabama at Birmingham, Birmingham

CRU de Tours - Hôpital Bretonneau, Hématologie -Thérapy Cellulaire, Tours

Vanderbilt Ingram Cancer Center, Nashville

Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant Orsola-Malpighi, Bologna

The Ohio State University and Wexner Medical Center, James Cancer Hospital, Columbus

University of Michigan, Ann Arbor

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Centre Hospitalier Lyon Sud, Pierre-Bénite

University of Oklahoma Stephenson Cancer Center, Oklahoma City

MD Anderson Cancer Center, Houston

CliniCore Texas, Houston

START- South Texas Accelerated Research Therapeutics, San Antonio

USC/Norris Comprehensive Cancer Center, Los Angeles

Cedars-Sinai Medical Center, Los Angeles

Gustave Roussy Cancer Campus (IGR), Villejuif

UC Davis Medical Center, Sacramento

Oregon Health and Science University, Portland

University of Washington, Seattle Cancer Care Alliance, Seattle

HonorHealth Research Institute, Scottsdale

Simlow Cancer Hospital at Yale, New Haven

Tufts Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Dartmouth-Hitchcock Medical Center (DHMC), Lebanon

Summit Medical Group - Florham Park Campus/Atlantic Health, Florham Park

Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne, Yvoir

Tom Baker Cancer Centre, Calgary

Szabolcs-Szatmár-Bereg Megyei Kórházak És Egyetemi Oktatókórház, Nyíregyháza

Instituto Europeo di Oncologia, Milan

Azienda Socio Santaria Territoriale Monza- Osperdale San Gerado, Monza

Institut Catala d'Oncologia, Girona

British Columbia Cancer Agency, Vancouver

Cancer Care Manitoba, Winnipeg

Nova Scotia Health Athority-Qeii HSC, Halifax

Sunnybrook Hospital, Toronto

Princess Margaret Cancer Centre, Toronto

Jewish General Hospital, Montreal

Centre Antoine Lacassagne, Oncologie Médicale, Nice

Centre Henri Becquerel, Hematology, Rouen

University Hospitals of Leicester NHS Trust, Leicester

University Hospital Southhampton NHS Foundation Trust - Somers Cancer Research, Southampton

Churchill Hospital, Oxford University Hospital NHS Trust, Oxford

The Royal Marsden NHS Foundation Trust, Sutton

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham

Beatson Cancer Center and University of Glasgow, Glasgow

University College London Hospitals NHS Foundation Trust, London

Guy's and Saint Thomas' NHS Foundation Trust, London

The Christie NHS Foundation Trust, Christie Hospital, Manchester